Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) - Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS)

Roncolato, Ft; Berton-Rigaud, D; O'Connell, R; Lanceley, A; Sehouli, J; Buizen, L; Okamoto, A; Aotani, E; Lorusso, D; Donnellan, P; Oza, A; Avall-Lundqvist, E; Berek, J; Hilpert, F; Ledermann, Ja; Kaminsky, Mc; Stockler, Mr; King, Mt; Friedlander, M.